REGULATORY ROLE OF INFLAMMATORY MEDIATORS IN THE PATHOGENESIS OF ORAL INFLAMMATORY DISEASES: A REVIEW
Authors/Creators
- 1. Senior Lecturer at the Faculty of Medicine, Namangan State University, Namangan, Uzbekistan. ,Senior Lecturer at the Faculty of Medicine
- 2. Candidate of Medical Sciences, Associate Professor
- 3. 2nd-year Student, Faculty of Dentistry
- 4. Doctor of Medical Sciences, Professor,Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan, Kazakhstan.
- 5. Candidate of Medical Sciences, Associate Professor, Tashkent State Medical University, Tashkent, Uzbekistan.
Description
Inflammatory diseases of the oral cavity are increasingly recognized as immune-mediated disorders in which disease progression is largely determined by dysregulated host inflammatory responses rather than by microbial factors alone. This review aimed to analyze the regulatory role of inflammatory mediators in the pathogenesis of periodontitis and pulpitis and to evaluate their diagnostic and therapeutic significance.
A structured literature search was conducted using PubMed, Scopus, Web of Science, and Google Scholar databases for publications published between 2000 and 2025. Relevant studies addressing cytokines, chemokines, matrix metalloproteinases, oxidative stress, lipid mediators, osteoimmunology, and host-modulation therapy in oral inflammatory diseases were included.
The analysis demonstrated that IL-1β, TNF-α, IL-6, IL-17, reactive oxygen species, matrix metalloproteinases, and the RANKL/OPG axis play central roles in inflammatory tissue destruction and chronicity. In addition, increasing evidence supports the concept of defective inflammation resolution associated with impaired specialized pro-resolving mediator pathways. Biomarker analysis of saliva and gingival crevicular fluid appears promising for disease monitoring and personalized therapeutic strategies.
Inflammatory mediator regulation represents a key pathogenetic mechanism in oral inflammatory diseases and may serve as a promising target for biomarker-guided diagnostics and host-modulation therapy in personalized dental medicine.
Files
18-32.pdf
Files
(274.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:9934aa74a6228d32e361262195a9f5a0
|
274.8 kB | Preview Download |
Additional details
References
- Page RC, Kornman KS. The pathogenesis of human periodontitis: an introduction. Periodontol 2000 1997;14:9–11. https://doi.org/10.1111/j.1600-0757.1997.tb00189.x.
- Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers 2017;3:17038. https://doi.org/10.1038/nrdp.2017.38.
- Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809–20. https://doi.org/10.1016/S0140-6736(05)67728-8.
- Rechenberg DK, Galicia JC, Peters OA. Biological Markers for Pulpal Inflammation: A Systematic Review. PLoS One 2016;11:e0167289. https://doi.org/10.1371/journal.pone.0167289.
- Hajishengallis G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol 2014;35:3–11. https://doi.org/10.1016/j.it.2013.09.001.